Retroviral restriction by APOBEC proteins
- PMID: 15516966
- DOI: 10.1038/nri1489
Retroviral restriction by APOBEC proteins
Abstract
A powerful mechanism of vertebrate innate immunity has been discovered in the past year, in which APOBEC proteins inhibit retroviruses by deaminating cytosine residues in nascent retroviral cDNA. To thwart this cellular defence, HIV encodes Vif, a small protein that mediates APOBEC degradation. Therefore, the balance between APOBECs and Vif might be a crucial determinant of the outcome of retroviral infection. Vertebrates have up to 11 different APOBEC proteins, with primates having the most. APOBEC proteins include AID, a probable DNA mutator that is responsible for immunoglobulin-gene diversification, and APOBEC1, an RNA editor with antiretroviral activities. This APOBEC abundance might help to tip the balance in favour of cellular defences.
Similar articles
-
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.Med Sci Monit. 2006 May;12(5):RA92-8. Med Sci Monit. 2006. PMID: 16641889 Review.
-
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.Curr Biol. 2003 Nov 11;13(22):2009-13. doi: 10.1016/j.cub.2003.10.034. Curr Biol. 2003. PMID: 14614829
-
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.Nature. 2003 Jul 3;424(6944):99-103. doi: 10.1038/nature01709. Epub 2003 May 28. Nature. 2003. PMID: 12808466
-
APOBEC-mediated editing of viral RNA.Science. 2004 Jul 30;305(5684):645. doi: 10.1126/science.1100658. Science. 2004. PMID: 15286366
-
APOBEC-mediated viral restriction: not simply editing?Trends Biochem Sci. 2007 Mar;32(3):118-28. doi: 10.1016/j.tibs.2007.01.004. Epub 2007 Feb 15. Trends Biochem Sci. 2007. PMID: 17303427 Review.
Cited by
-
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.JCO Precis Oncol. 2022 Oct;6:e2200149. doi: 10.1200/PO.22.00149. JCO Precis Oncol. 2022. PMID: 36315915 Free PMC article.
-
Synthesis and Bioactivity of N-(4-Chlorophenyl)-4-Methoxy-3-(Methylamino) Benzamide as a Potential Anti-HBV Agent.Drug Des Devel Ther. 2020 Sep 15;14:3723-3729. doi: 10.2147/DDDT.S263701. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32982177 Free PMC article.
-
Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy.Int J Clin Exp Med. 2015 May 15;8(5):7762-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221327 Free PMC article.
-
APOBEC3 proteins and genomic stability: the high cost of a good defense.Cell Cycle. 2012 Jan 1;11(1):33-8. doi: 10.4161/cc.11.1.18706. Epub 2012 Jan 1. Cell Cycle. 2012. PMID: 22157092 Free PMC article.
-
Role of the host restriction factor APOBEC3 on papillomavirus evolution.Virus Evol. 2015 Jan;1(1):vev015. doi: 10.1093/ve/vev015. Epub 2015 Jan 1. Virus Evol. 2015. PMID: 27570633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous